Torrent Pharmaceuticals Limited (TORNTPHARM) initiates a voluntary recall for select Semalix injection pens due to technical evaluation by manufacturer Dr.
Torrent Pharmaceuticals Limited (TORNTPHARM) reports a 43% revenue increase in Q4 FY26, reaching ₹2,215 crore.